Exploring Pediatric NLPHL: Insights from a Low-Middle-Income Country
Brittney Abernathy, Journal Manager Oncology Reviews and Frontiers in Cancer Control and Society, shared on LinkedIn:
“Exploring Pediatric NLPHL: Insights from a Low-Middle-Income Country
This comprehensive study delves into pediatric nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), offering valuable insights into its complexity, treatment challenges, and outcomes. It examines the effectiveness of different chemotherapy regimens and highlights the importance of tailored treatment approaches, particularly in resource-limited settings.
Understanding the evolving nature of NLPHL treatments is crucial for improving patient outcomes globally. This study emphasizes the potential of R-CHOP over ABVD, showing better progression-free survival rates. The findings highlight that early-stage NLPHL patients have excellent survival rates, but challenges remain for advanced-stage treatment.
What innovative strategies do you believe could further enhance treatment for NLPHL globally?”
Authors: Youssef Madney, Amr Abdalla, Soha Ahmed, Marwa Romeih, Sally Fikry, Engy Mohammed, Hala Taha, Mohamed Zaghloul, Eman Attia
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023